Market Access Beyond Market Access: Why healthcare-system understanding is... Healthcare-system literacy, and the ability to contribute to system shaping, must become part of how healthcare leaders make decisions.
Market Access Pharma’s most expensive question is the last one asked Whether a drug can secure reimbursement is pharma's billion-dollar question, and the companies that succeed will be those that answer it sooner.
News Jen Norton appointed market access leader at EVERSANA EVERSANA has named Jen Norton as president of its recently formed Market Access & Value division.
R&D Strategies for creating an ecosystem to support early-stage ... Learn how to foster growth for early-stage biotech companies through innovative ecosystem strategies and valuable CDMO collaborations
Market Access Sponsored The stealth market access strategy that’s quietly making man... There is an under-the-radar market access strategy that some manufacturers have implemented, but many others remain unaware of.
Market Access Partner Content The Inaugural Market Access for CNS Therapeutics Summit Has ... The only dedicated forum focused on tackling the unique commercial and reimbursement challenges facing treatments for neurodegeneration...
News argenx's Forte acquisition delivers coeliac trial win argenx's CD122 inhibitor FB102, added to its pipeline through the $2.2bn acquisition of Forte, is moving into phase 3 testing for coeliac disease.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.